johnson & johnson - Search News

Johnson & Johnson's Spravato nasal spray okayed

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

U.S. News & World Report · 1d

FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral antidepressants,

Fast Company on MSN · 1d

Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral antidepressants. On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray,

Ben Johnson Is Firing 5 Bears Coaches

USA Today · 1d

New Chicago Bears head coach Ben Johnson says he enjoyed beating Packers' Matt LaFleur twice a year as Lions offensive coordinator

New Chicago head coach Ben Johnson didn't waste any time jumping into the Packers-Bears rivarly with his comments directed at Matt LaFleur.

FOXSports on MSN · 6h

Bears coach Ben Johnson says his offense won't 'look the same as it did in Detroit'

New Bears HC Ben Johnson joined FS1's "Breakfast Ball" and "The Herd" to share what he might do to unlock Caleb Williams' potential.

Tribune News Service on MSN · 9h

Paul Sullivan: George McCaskey gets a rare ‘W’ with the hiring of Ben Johnson as the next Bears coach

Chicago Bears Chairman George McCaskey sat through a nightmarish loss to the Seattle Seahawks that was punctuated with fans at Soldier Field chanting “Sell the team.” McCaskey didn’t take the hint, and on Wednesday he was back in their good graces,

21h

Johnson & Johnson: Hold Rating Amid Mixed Performance and Future Uncertainties

Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...

14h

Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

Supply Chain4h

Podcast | How Healthcare Giant Johnson & Johnson Is Making Its Supply Chain Sustainable

How is one of the world’s largest pharmaceutical companies promoting sustainability and regulatory compliance throughout its ...

22h

Balanced Expectations Amid Challenges and Opportunities for Johnson & Johnson: Hold Rating Issued

Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lee ...

The Motley Fool1d

Johnson & Johnson (NYSE: JNJ)

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...